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Summary 
It has been demonstrated that neutrophils from healthy donors or from patients with inflamma- 
tory disorders  can bind immunoglobulin (Ig) E proteins through binding to Mac-2/ebp. Func- 
tional responses  to allergens  were assessed by measuring the respiratory burst and intracellular 
Ca  2+ levels, and binding of allergens to neutrophils was assessed by flow cytometry analysis and 
fluorescence microscopy. In this article,  we demonstrate that neutrophils sensitized to specific 
allergens  (from allergic patients), but not from healthy donors, are sensitive  to allergens  of the 
same type as those that produce clinical allergic symptoms. The activation of neutrophils was 
analyzed by the induction of a  respiratory burst that was detected with luminol-dependent 
chemiluminescence. Intracellular Ca  2§  levels increased parallel  to those of the inducing aller- 
gens. In addition, the specific binding of allergens  on the cell surface was revealed by flow cy- 
tometry and aUergen-FITC-labeled staining analyses. The present data suggest a restricted rec- 
ognition of allergen by sensitive neutrophils, probably associated  with the specific  binding of 
the allergen to its corresponding IgE molecule, which is bound to the Mac-2/~bp structure. 
These findings demonstrate a functional role of allergen-associated neutrophils during the aller- 
gic state. 
T 
he development of an immediate hypersensitivity re- 
action involves various biochemical events leading to 
the release  of histamine, arachidonic acid metabolites, an- 
ion superoxide, and other effector molecules (1, 2). All in- 
flammatory cells  (macrophages,  lymphocytes,  mast  cells, 
eosinophils, neutrophils, and platelets)  have been shown to 
be involved in asthma, but the relative role of each cell is 
not completely understood (1). Because of the chronic na- 
ture of allergic  diseases, leukocytes that persist  in the lung 
tissue,  especially  eosinophils  and  lymphocytes,  have  be- 
come more  strongly associated  with the  disease.  For this 
reason, neutrophils have often been neglected in studies on 
allergic  diseases. However, there is increasing evidence of 
neutrophil participation in asthma and the allergic process. 
For instance, plasma chemotactic activity ofneutrophils in- 
creases,  and peripheral-blood neutrophils show markers of 
activation, during active asthma (3), after exercise-induced 
asthma (4), and during early and late asthmatic reactions in- 
duced by allergens  (5) and toluene diisocyanate (6). In sub- 
jects with pollen-induced asthma, seasonal antigenic exposure 
is associated with an increase in the number of neutrophils 
shown in bronchial biopsies  (7). In other atopic asthmatics, 
local  endobronchial  allergen  challenge leads  to  increased 
neutrophil infiltration of the airway mucosa (8). Further- 
more,  activated  neutrophils  can  induce  airway  hyper- 
responsiveness  (9). Most of the  cells, such as eosinophils, 
epidermal Langerhans cells,  macrophages/monocytes, and 
bronchial epithelial cells,  selectively express  two types of 
IgE receptors,  namely, receptors of high affinity (Fc~RI) 1 
and of low affinity (FceRII) (10-15). Although neutrophils 
express  neither Fc~RI nor Fc~RII receptors for IgE  (10, 
16), evidence has been presented that neutrophils express a 
new family of IgE-binding receptors, which belong to the 
S-type lectins. Among them, Mac-2/ebp is the best charac- 
terized,  and its presence  in neutrophils has been demon- 
strated (17,  18). The presence of this new family oflgE re- 
ceptors  has  been  previously  demonstrated  in  other  cells 
(19-21).  Stimulation of human neutrophils induces several 
phenomena known collectively as respiratory burst, charac- 
terized by an increase in the production of superoxide an- 
ion (22, 23). Although the generated inflammatory media- 
tors are critical  to the host defense role of the neutrophils, 
they can cause  severe tissue  damage when excessively or 
inappropriately produced (24). 
1Abbreviations used in  this paper: CL,  chemiluminescence; FceRI and 
FceRIl, high and low affinity  IgE Fc receptors, respectively. 
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phils can directly interact with the allergens, and if so, what 
the  functional response  is.  The  present  work was  under- 
taken to analyze these questions. The rationale is that neu- 
trophils  from  allergic  patients  possess  specific  IgE  pre- 
attached to the surface of these cells. Challenging with  an 
allergen could trigger the activation of neutrophils through 
the  IgE-~bp complex in the membrane.  Here we present 
evidence that specific allergens were able to activate respi- 
ratory burst from asthmatic patients sensitized to those al- 
lergens, and we have found a relationship between the two 
parameters (that is, the respiratory burst is closely related to 
sensitized neutrophils). Moreover, we found that increased 
respiratory  burst  was  associated  with  enhanced  antigen- 
dependent  Ca  2+  elevation  by  neutrophils  from  allergic 
patients.  In  addition,  sensitized  neutrophils  from  allergic 
patients specifically bound FITC-labeled allergens, as mea- 
sured by fluorescence microscopy and flow cytometry. 
Materials and Methods 
Materials.  The allergens studied included D 1 (Dermatophagoides 
pteronyssinus), G 3 (Dactylisglomerata), T 9 (Olea europea), and W6 (Ar- 
temisia vulgaris). They were purchased from Ifidesa-Aristegui (Bil- 
bao, Spain). Mezerein was from Sigma-Aldrich Co. Ltd. (Poole, 
Dorset, England). Other biochemicals were from Sigma or Merck 
(Barcelona, Spain). 
Patients and Controls.  The group studied included adult atopic 
patients with bronchial asthma and healthy adult nonatopic vol- 
unteer controls. The asthmatic patients had positive skin prick test 
(Ifidesa-Arlstegui) and specific IgE (CAP, Pharmacia Ib6rica, Bar- 
celona, Spain)  to at least one common allergen (house dust mites 
and pollens). The subjects received neither treatment nor specific 
hyposensitization. None  of them  had  experienced episodes of 
asthma for at least 3 too, and none had had respiratory tract infec- 
tions for 4 wk before blood sampling. The healthy controls had 
no history of allergy or bronchial symptoms and had negative skin 
prick test (Ifidesa-Aristegui) and specific IgE to a battery of inhalant 
allergens (house dust mites, pollens, molds, and animal danders). 
Preparation of Polymorphonuclear Leukocytes.  Human  neutrophils 
were  purified  (25)  from  freshly drawn  heparinized  (10  U/ml) 
venous blood in two  steps:  first,  the blood (20  nil) was mixed 
with 1.5 ml of 10% Dextran T  500 (final concentration of 0.7%), 
dissolved in PBS. The supernatant fraction was centrifuged through 
a Ficoll-Hypaque. The neutrophil-rich pellet was then removed 
by plastic pipette and red cells were eliminated by one hypotonic 
lysis in water. Neutrophils were resuspended to "~107 cells/ml in 
PBS and 10 mM of glucose and were kept at room temperature. 
Measurement of lntracellular Ca  2+.  Freshly prepared  neutrophils 
from  allergic or  healthy  donors  were  incubated  in  a  medium 
(Ca  2+  medium)  composed of 137  mM  NaC1,  2.7  mM  KC1,  1 
mM MgC1,  1 mM CaC12, 20 mM Hepes at pH 7.4, at a concen- 
tration of 107  cells/ml at  37~  for 45  rain in  the presence  of 
2 btM Fura-2 acetoxymethyl ester (26). The excess of the dye was 
then washed away,  and the  neutrophils were kept in the  same 
medium. Batches of 107 cells were resuspended in 0.6 ml of Ca  2§ 
medium at 37~  and the allergens to be studied were added to 
the cellular suspension. Fura-2 fluorescence (k~x  ~ at 340 nm and 
ke,,~ at 505  nm) was recorded on a Perkin-Elmer (Norwalk, CT) 
LS-5 spectrofluorimeter. Ca  2+ was calibrated with a value of 224 
for the K d of Fura-2. 
Measurement of Chemiluminescence.  Luminol-amplified chemi- 
luminescence (CL)  was measured in a Berthold luminometer at 
37~  basically as described in reference 27.  Briefly, neutrophils 
(106 cells/ml)  were  incubated  in  1  ml  of PBS  buffer  supple- 
mented with  10 mM  glucose, 500  }~M  CaC12, 5  I~M luminol, 
100  I~M sodium azide for 5 rain. Then allergens as stimulants at 
the indicated doses were added, to give a final volume of 1 ml. 
The CL response was measured every 1 rain in each tube. Data 
were expressed as the number of cpm recorded each minute over 
a 15-rain period. 
Coupling of FITC to Allergen Protein.  Coupling was carried out 
with a conjugation kit in accordance with the instructions of the 
manufacturer (Quicktag FITC Conjugation Kit; Boehringer Mann- 
helm Corp., Indianapohs, IN). 
Coupling of Allergen Labeled with FITC to Neutrophils.  This cou- 
phng was carried out as previously described (28), with minor mod- 
ifications. In brief, after fixing in 3% paraformaldehyde, 7  ￿  10  ~' 
cells in PBS with  10 mM glucose were incubated with allergen 
labeled with FITC  (100  ~g/ml)  for  16-18  h  at 4~  The  cells 
were spun (500 rpm, 4~  5 rain), and were decanted, 10 ml of 
PBS,  1% HSA was  added, and the cells were resuspended, and 
spun again. This washing was repeated three more times. Finally 
the cells were resuspended in 500 bd of PBS, 10 mM glucose. 
Fluorescence Staining  for Microscopy Analysis.  The  method  pre- 
viously described (29),  with minor modifications, was followed. 
Neutrophils were fixed for 20  rain in  3%  paraformaldehyde in 
PBS buffer, pH 7.4. After washing, cells (1.5  ￿  10  s cells per 40 
l-d) were suspended in PBS with  10 mM  glucose and were at- 
tached to polylysine coated slides for 30 min at 25~  Cells were 
incubated with specific allergen, labeled with FITC, for 16-18 h 
at  4~  in  the  dark and  in  a  humid  chamber.  The  slides  were 
rinsed with PBS with l% HSA once and rinsed again with PBS 
alone. Shdes were processed for epifluorescence microscopy using 
10% PBS, 90% glycerol as mounting medium. 
Flow Cytometry Analysis.  Flow cytometry was  performed on 
an Epics Elite flow cytometer (Coulter Corp., Hialeah, FL) and 
calibrated by standard techniques.  For each stained sample, 2  ￿ 
104 cells were analyzed for FITC fluorescence intensity. The flu- 
orescent distribution for both control (cell autofluorescence) and 
test cells with allergen labeled with  FITC was analyzed with  a 
Coulter Elite software workstation. 
Results 
Respiratory  Burst.  Fig. 1, A  and B, illustrates the kinetic 
effect  of G 3 allergen  on  respiratory burst  for  neutrophils 
obtained from  two  patients  who  expressed high levels of 
specific IgE for the  G3 pollen. The  onset of luminescence 
began 2  rain after the  G3 additions in both cases.  Samples 
from all patients studied (n  =  12)  gave a  similar response. 
The kinetic study shows that maximum levels for each dose 
of allergen are obtained 7-8 rain after the addition of G3 to 
cells. Plotting the luminescence data from Fig. 1 against the 
dose of G3 shows a  sigrnoid relationship between the two 
parameters (Fig. 2). This could suggest some type of coop- 
eration in the occupation by the allergen of the IgE-bind- 
ing sites located on  the surface of cells. Neutrophils from 
healthy  donors  were  always  simultaneously  assayed  and 
taken as controls. After G3 challenge in these cells, no dif- 
ference in values was detected (data not shown). 
Fig. 3  shows the specificity of the response to allergens. 
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Figure  1.  Activation of neutrophils by a spe- 
cific  allergen  (G3).  Neutrophils  isolated  from 
two  allergic  patients  (each  represented  sepa- 
rately in A  and B)  were  suspended (106  cells/ 
ml) in  1 ml of PBS buffer supplemented with 
10 mM glucose, 500 ~M CaC12,  100  p~M so- 
dium azide  and the addition  of different con- 
centrations of G3, at the following final concen- 
trations:  1 (O), 2  ([]),  3  (A), 5  (V), 7  (O),  10 
(￿9  and  15  I~g/ml (0).  At the same time,  5 
~M luminol was added. The suspension was in- 
cubated  at  37~  and  the  chemiluminescence 
response was recorded for  10 min. Similar re- 
sults were obtained in at least eight other exper- 
iments using neutrophils from different patients 
with clinical allergies to G 3 allergen. 
Neutrophils from a patient who was specifically allergic to 
G 3 show a clear response when cells were incubated with 
this pollen. However, when cells were incubated with D 1 
or T9 (to which the patient was not sensitized), no respira- 
tory burst was detected. In other experiments, neutrophils 
from patients allergic to T 9 or D 1 were incubated with the 
specific pollen. Fig.  4 illustrates  a dose-dependent response 
in the activation of respiratory burst when cells were chal- 
lenged with different doses ofT  9 (A) or D 1 (B).  These data 
show  evidence that  the  activation of respiratory burst  in 
sensitized neutrophils is not restricted by the type of aller- 
gen. The specificity of the response to allergens was further 
assessed with neutrophils from subjects without any allergic 
pathology. Fig.  5 illustrates  the absence of response to  G3, 
T9, D1, and W6 in neutrophils from a healthy donor who is 
not sensitive to those allergens. Another seven separate ex- 
periments performed on neutrophils from healthy donors 
gave similar results (data not shown). The respiratory burst 
was  normal when  cells  were treated with mezerein. This 
indicates that the lack of response to these pollens was due 
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Figure 2.  Dose-dependence of a grass (G3) on respiratory burst by sen- 
sitized neutrophils. Shown values were taken from Fig.  1 at 7 min of in- 
cubation. 
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to some alteration in the binding of pollen to  the mem- 
brane (e.g., no recognition of the stimulus or absence of re- 
ceptor [IgE]  for the antigen) but not in the mechanism of 
the NADPH-oxidase complex. 
Next,  experiments were performed to analyze whether 
unspecific anti-IgE could induce the stimulation of respira- 
tory burst. To this end, neutrophils from allergic or healthy 
donors were incubated with 0.8 mg/rnl or 1.2 mg/ml of 
anti-IgE.  Fig.  6  illustrates  that  both  preparations  of cells 
(i.e., allergic [A] and nonallergic [B]) produced a clear and 
rapid increase  in  respiratory burst.  This finding seems  in 
agreement with the fact that neutrophils express IgE mole- 
cules in a significant percentage (18). 
Ca  2+ Mobilization  and Binding of Allergens  to SuoCace Cells. 
Early work indicates that mobilization of intracellular Ca  2+ 
plays a role in the onset of respiratory burst (30),  although 
this has been discussed by others (31). In the present study, 
we address  the issue  of whether Ca  2+  participates in aller- 
gen-induced respiratory burst. Fig.  7 illustrates  that in neu- 
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Figure 3.  Specific activation of sensitized neutrophils by different aller- 
gens. Neutrophils from a patient allergic to G 3 were challenged with G3, 
T 9 and D 1 allergens.  Other  experimental conditions were  as in Fig.  1. 
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Figure  4.  Specific activation  of  sensitized 
neutrophils by T 9 (A) or D]  (B) allergens. (A) 
Neutrophils  from a patient allergic to T9 were 
challenged with different concentrations of T,, 
as indicated in the figure. (B) Neutrophils from 
a  patient  allergic to  D~  were  incubated  with 
two  concentrations  of D,, as indicated  in the 
figure. Other experimental conditions were  as 
in Fig.  1.  Typical result of two  other  experi- 
ments is shown. 
trophils from allergic patients,  Ca  2+  levels increased when 
the cells were challenged with the specific allergens. Thus, 
neutrophils from patient 1, sensitized to D1 and G3 (Fig. 7, 
1-a  and  I-b)  showed  a  clear  mobilization of Ca  2+  levels 
when they were incubated with Di, at 30 Izg/ml, or G3 at 
indicated concentrations. In this last case, a dose-dependent 
response was observed.  In neutrophils from patient 2  (Fig. 
7,  2-a  and  2-b),  sensitized  to  D 1 and  T9,  and  challenged 
with these pollens, a similar increase of Ca  2+ was detected, 
although at a lower level. In patient 3  (Fig. 7, 3-a and 3-b), 
who gave a negative result for D I and positive to W  9 in the 
skin test,  these  allergens altered  the  Ca  2+  levels according 
their allergic capacity.  With neutrophils from healthy do- 
nors, no Ca  2+ mobilization after the addition of these aller- 
gens was observed (data not shown).  In addition, there was 
a high degree of specificity in the response, since it was not 
altered either by other allergens (to which the patients were 
not sensitive) or by neutrophils from healthy donors. Fig. 8 
illustrates  that  the  addition  of anti-lgE Ab  to  neutrophils 
from an allergic patient and from healthy donors produced 
an increase in Ca  2+  levels.  This  was  corroborated  in four 
separate  experiments.  Challenging  neutrophils  with  anti- 
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Figure  5.  Lack  of response to allergens by 
neutrophils from healthy donors. Neutrophils 
(106 cells/ml) from healthy donors were incu- 
bated with allergens, as indicated in the figure 
or with 100 ~M-mezerein (O). Similar results 
were  systematically obtained in 10 other ex- 
periments performed with cells from different 
donors. 
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Figure  6.  Effect  of anti-IgE on  neutro- 
phil  activation. Neutrophfls  (106 cells/nil) 
from an allergic (A) or a healthy (B) donor 
were incubated in triplicate with the indi- 
cated volumes of anti-IgE (from a prepara- 
tion at 1 bLg/ml). Chemiluminescence was 
recorded. Three separate experiments gave 
the same results. 
IgE Ab,  we systematically observed greater Ca  2+  levels in 
cells from allergic patients than from healthy donors. 
To  determine whether allergens can specifically bind to 
neutrophils, we searched for an FITC-labeled allergen ca- 
pable of staining the cells isolated from allergic subjects. As 
observed in Fig. 9, flow cytometry studies demonstrated an 
increased binding of FITC-labeled G3 and T 9 (c and d) in 
neutrophils  from  patients  with  allergy  to  these  pollens, 
compared  with  FITC-labeled D1  (to  which  the  patients 
were  not  sensitive  [b])  or  from  cell  autofluorescence  (a). 
These  data verify the linking of allergens to  structures lo- 
cated on the surface of sensitized neutrophils and, in addi- 
tion, the specificity of such linking. These structures capa- 
ble  of binding  allergens  are  presumably  the  Mac-2/ebp 
receptor-IgE  complex,  as  was  demonstrated  previously 
(21).  The  attachment  of neutrophils from  allergic patients 
to  FITC-labded  G3  was  further  assessed  by  microscopy 
analysis of stained cells. Fig. 10 illustrates the interaction of 
labeled allergens and  neutrophils.  As  expected  from  flow 
cytometry  data,  only  cells  from  patients  sensitized  to  G 3 
were positively stained (Fig. 10 A). By contrast, D 1 added 
to neutrophils from a subject who was not sensitive to this 
allergen did not give any fluorescence signal, or it was very 
weak (Fig. 10 C). Also, neutrophils from patients sensitized 
to T 9 (Fig. 10 E) or D 1 (Fig. 10  G) were positively stained 
when they were challenged with the specific FITC-labeled 
allergen. 
Discussion 
Activated neutrophils produce oxyradicals that are essen- 
tial for microbicidal and cytotoxic activities and play an im- 
portant role in the host defense system (32).  However, the 
overproduction of oxyradicals by neutrophils, as in chronic 
inflammatory diseases, may lead to severe local tissue damage. 
The  experiments  described  here  provide  the  first  evi- 
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Figure  7.  Ca  2+  increase  in 
neutrophils from  different aller- 
gic patients challenged with their 
specific  allergens. Neutrophils 
(107 cells/ml) from three allergic 
patients  who  presented  clinical 
symptoms as indicated: patient 1 
to D 1 and  G 3  (profiles l-a  and 
t-b); patient 2 to DI and T 9 (pro- 
files 2-a  and 2-b);  and patient 3 
tO T 9 only (profiles 3-a and 3-b). 
The cells  were loaded with Fura- 
2AM, and intracellnlar Ca  2+ was 
analyzed. The added dose of al- 
lergens was 30 Ixg/ml in all cases, 
except in  l-b,  where  it is indi- 
cated in the  margin  (in micro- 
grams per milliliter). A  B 
400 
z  300 
§ 
o  200  K.J 
1 O0 ~ 
3.3 
2.0 
1.3 
0.6 
=~-lgE 
2rain 
l{-I  g  E 
Figure  8.  Ca  2+ mobilization induced by anti-IgE. Loaded 
Fura-2AM  neutrophils  (107 cells/ml)  from  allergic  (A)  or 
healthy (B) donors were incubated with the indicated doses 
of anti-IgE, and changes in Ca  z+ levels were analyzed. 
dence that neutrophils from allergic patients are sensitive in 
vitro to specific allergens that lead to their activation. Neu- 
trophil  activation  was  initiated  when  specific  allergens 
bound to preattached surface IgE molecules. This activated 
state was  evidenced by a  clear increase in  the  respiratory 
burst  of the  neutrophils from allergic patients when they 
were incubated in the presence of allergens.  The apparent 
half-maximal dose (~30 p,g/ml) calculated for G 3 allergen 
from data presented in Fig.  2 is in keeping with data ob- 
served for other biochemical systems.  Thus, in T  cell pro- 
liferation studies, the effective doses of  allergens were in the 
range of 0.1-30.0  p,g/ml (33),  and in the analysis  of IL-4 
production by CD4+  T  cell clones, the concentration of 
50  p,g/ml of allergen was studied (34).  Also, in mononu- 
clear cells, the synthesis of IL-4 and IFN-~/was induced by 
10 p,g/ml of allergen (35). Our results indicate that in vitro 
activation of neutrophils was very specific for certain aller- 
gens.  Thus, allergens other than those that produce clinical 
symptoms did not stimulate the respiratory burst, and also, 
allergens were ineffective on neutrophils from healthy do- 
nors. Present data also show that the activation of cells by 
allergens was rapid ('~1 rain) and that the magnitude of re- 
spiratory burst was dependent on the dosage of allergen. 
The nature  of the  mechanisms  whereby allergens pro- 
mote the respiratory burst is not fully understood. Our re- 
sults  suggest that allergens are bound to preformed struc- 
tures on the neutrophil membrane. The pivotal observation 
was made recently by Truong et al. (18). Besides the well- 
known receptors (e.g., FceRI and FcelklI) for IgE (10-15), 
a third type of IgE-binding structure has been described by 
these authors, the so-called IgE-binding protein, ebp (18). 
cDNA  coding for rat  and  human  ebp  revealed that  this 
protein  is  distinct  from  FceRI  and  FcelKII  (36).  Subse- 
quently, it was demonstrated that ebp is identical to CBP35 
g_ 
.i 
d,  : 
~,  ."  _ 
E~, .?  ! 
~  L J  ￿9 .  :.', 
.  d~'e  ,%.  -~  \ 
.  t..21" 
~  i  I  I  U  i Ipl  -U  I  ~  i  I  I  l  i  I  !  i  n  u  I  i  U  ,  n  u  I  I  "'~  I  U  i  .U  I  I  i  I  i 
1  10  leo  10e8 
LOG FLUORESCENCE  INTENSITY 
Figure 9.  Binding of FITC-labeled aller- 
gens  to  neutrophils  analyzed  by  flow  cy- 
tometry.  After  fixing  in  3%  (wt/vol) 
paraformaldehyde,  neutrophils  (7  ￿  10  6 
cells/ml)  from a  patient  allergic to  G 3 and 
T 9 were  incubated at  4~  for  18  h,  either 
without additions (a)  or in the presence of 
FITC-labeled D 1 (b), G 3 (c) and T9 (d), and 
were further processed as indicated in Mate- 
rials  and  Methods.  Data  correspond  to  an 
experiment  representative  of  three  per- 
formed. 
Figure  10.  Fluorescence microscopy location of FITC-labeled allergens bound to neutrophils. Cells from G 3 (A-D), T 9 (E and F), or D 1 (G and H) 
allergic donors were fixed and plated to polylysine-coated slides. Slides were incubated with FITC-labeled G 3 (A and B) and FITC-labeled D1 (C and D) 
(to which the patient was not sensitive), FITC-labeled T 9 (E and F ), or FITC-labeled D1 (G and H) for 18 h at 4~  and processed as indicated in Ma- 
terials and Methods for fluorescence microscopy (A, C, E, and G) and light microscopy (B, D, F, and H). 
2576  Enhancement of Antigen~pecific Functional Responses (37), Mac-2 (19), and HL-29 (38). All these structures share 
common characteristics, including a molecular mass of 29- 
35 kD (39).  It is noteworthy that neutrophils represent the 
only blood cell population that does not express conven- 
tional Fc receptors for IgE. Truong et al. (18) also observed 
that the addition of polyclonal IgE antibodies increased the 
respiratory  burst  in  neutrophils  from  healthy  donors. 
Present data (Fig.  8) are in agreement with this observation 
and, in addition, extend the study to populations ofneutro- 
phils from allergic patients. 
On the basis  of previous data  (17),  it may be hypothe- 
sized  that  allergens  could  bind  to  specific  IgE antibodies 
that are previously linked to its receptors. This mechanism, 
based on the  specificity of the  binding between  allergens 
and IgE molecules, would explain why neither neutrophils 
from healthy  donors  nor the  presence  of other  allergens 
different to those that have previously sensitized the neu- 
trophils stimulates respiratory burst. In these cases, allergens 
are not specifically bound to the preexistent IgE molecules 
on  the  cell  surface,  and  the  neutrophils  remain  inactive. 
Conceivably the addition ofpolyclonal anti-IgE antibodies 
triggers a response that is the same as the one produced by 
its natural ligands (e.g., allergens). 
With  regard  to  the  intracellular  molecular events  trig- 
gered by the  interaction  of allergens,  our data show  evi- 
dence that Ca  2+ is mobilized. Previously it had been shown 
that  intracellular  Ca  >  mobilization  is  a  requirement  for 
respiratory burst  (30).  The mechanism by which an aller- 
gen induces  Mac-2-mediated signal  transduction  in  neu- 
trophils is  unknown  at the  present.  By analogy with  the 
high-affinity receptor for IgE (Fc~RI), it may be postulated 
that the covalent modification by phosphorylation through 
protein-tyrosine kinase as well as through serine/threonine 
kinases  is  an  early molecular event  occurring  after cross- 
linking  of the  Mac-2  receptor.  It is  noteworthy  that  the 
observed response in Ca  2+ production was very rapid after 
challenge of neutrophils from allergic patients with a spe- 
cific allergen. 
Recently,  Yamaoka  et  al.  (40)  described  recombinant 
Mac-2/ebp  exogenously  added  to  human  neutrophils  as 
enhancing  superoxide  production.  This  observation  sug- 
gests  an  extracellular  function  of this  protein  once  it  has 
been exoxytosed (41).  Comparing these  with  the  present 
data (e.g., stimulation by allergens, reported in the present 
study, or by Mac-2/~bp, reported in [40]) may suggest that 
the  molecular  pathways  involved  in  the  stimulation  of 
NADPH--oxidase presumably act throughout  IgE binding 
on the cell surface. 
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